InvestorsHub Logo
Followers 97
Posts 6996
Boards Moderated 0
Alias Born 09/16/2010

Re: None

Wednesday, 01/03/2018 12:18:51 AM

Wednesday, January 03, 2018 12:18:51 AM

Post# of 29174
"We remain bullish on Canadian licensed producers and consider the following companies to be acquisition targets: Emblem (EMC.V) (EMMBF), Organigram (OGI.V) (OGMRF), Emerald Health (EMH.V) (EMHTF), Invictus MD Strategies (IMH.V) (IVITF), and Supreme Pharmaceuticals (FIRE.V) (SPRWF)."

https://technical420.com/cannabis-article/3-cannabis-themes-know-goldman-sachs-upgrade-canadian-ma-activity

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.